ImmunoCAP Specific IgE test: an objective tool for research and routine allergy diagnosis

Immunoglobulin (Ig) E-mediated allergic diseases are increasing rapidly, affecting the quality of life of millions of people and causing enormous costs for society. Accurately identifying the sensitizing allergen and its sources is one of the cornerstones in the clinical management of allergic patients. The original ImmunoCAP Specific IgE test (Pharmacia Diagnostics) is the only test for IgE antibodies sufficiently documented and recommended in research for advanced diagnosis and risk assessment. It is a reliable diagnostic tool and particularly useful in primary care where the use of in vivo tests cannot be recommended if the personnel have insufficient opportunities to get the appropriate experience.